Three-Year Outcomes in Kidney Transplant Patients Randomized to Steroid-Free Immunosuppression or Steroid Withdrawal, with Enteric-Coated Mycophenolate Sodium and Cyclosporine: The Infinity Study

In a six-month, multicenter, open-label trial, de novo kidney transplant recipients at low immunological risk were randomized to steroid avoidance or steroid withdrawal with IL-2 receptor antibody (IL-2RA) induction, enteric-coated mycophenolate sodium (EC-MPS: 2160 mg/day to week 6, 1440 mg/day the...

Descripción completa

Detalles Bibliográficos
Autores principales: Thierry, A., Mourad, G., Büchler, M., Choukroun, G., Toupance, O., Kamar, N., Villemain, F., Le Meur, Y., Legendre, C., Merville, P., Kessler, M., Heng, A.-E., Moulin, B., Queré, S., Di Giambattista, F., Lecuyer, A., Touchard, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960772/
https://www.ncbi.nlm.nih.gov/pubmed/24829794
http://dx.doi.org/10.1155/2014/171898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960772/
https://www.ncbi.nlm.nih.gov/pubmed/24829794
http://dx.doi.org/10.1155/2014/171898

Ejemplares similares